Research Article
Open Access
Dependence on Myb expression is attenuated in myeloid leukaemia with N-terminal CEBPA mutations
View ORCID ProfileGiacomo Volpe Correspondence email, Pierre Cauchy, David S Walton, View ORCID ProfileCarl Ward, Daniel Blakemore, Rachael Bayley, Mary L Clarke, View ORCID ProfileLuisa Schmidt, Claus Nerlov, View ORCID ProfilePaloma Garcia, Stéphanie Dumon, View ORCID ProfileFlorian Grebien, View ORCID ProfileJon Frampton Correspondence email
Giacomo Volpe
1Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK
2Key Laboratory of Regenerative Biology, Joint School of Life Sciences, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, and Guangzhou Medical University, Guangzhou, China
Pierre Cauchy
3Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany
David S Walton
1Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK
Carl Ward
1Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK
2Key Laboratory of Regenerative Biology, Joint School of Life Sciences, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, and Guangzhou Medical University, Guangzhou, China
Daniel Blakemore
1Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK
Rachael Bayley
1Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK
Mary L Clarke
1Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK
Luisa Schmidt
4Ludwig Boltzmann Institute for Cancer Research, Vienna, Austria
Claus Nerlov
5Medical Research Council Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK
Paloma Garcia
1Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK
Stéphanie Dumon
1Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK
Florian Grebien
4Ludwig Boltzmann Institute for Cancer Research, Vienna, Austria
6Institute of Medical Biochemistry, University of Veterinary Medicine, Vienna, Austria
Jon Frampton
1Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK
Published 15 March 2019. DOI: 10.26508/lsa.201800207
Statistics from Altmetric.com
Article usage
Myb dependence in CEBPA-mutant AML
Giacomo Volpe, Pierre Cauchy, David S Walton, Carl Ward, Daniel Blakemore, Rachael Bayley, Mary L Clarke, Luisa Schmidt, Claus Nerlov, Paloma Garcia, Stéphanie Dumon, Florian Grebien, Jon Frampton
Life Science Alliance Mar 2019, 2 (2) e201800207; DOI: 10.26508/lsa.201800207
Myb dependence in CEBPA-mutant AML
Giacomo Volpe, Pierre Cauchy, David S Walton, Carl Ward, Daniel Blakemore, Rachael Bayley, Mary L Clarke, Luisa Schmidt, Claus Nerlov, Paloma Garcia, Stéphanie Dumon, Florian Grebien, Jon Frampton
Life Science Alliance Mar 2019, 2 (2) e201800207; DOI: 10.26508/lsa.201800207
In this Issue
Volume 2, No. 2
April 2019
Advertisement
Jump to section
Subjects
Related Articles
- No related articles found.
Cited By...
- No citing articles found.